Department of Colorectal and Anal Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, People's Republic of China.
Surg Endosc. 2011 Oct;25(10):3175-82. doi: 10.1007/s00464-011-1683-4. Epub 2011 Apr 13.
Prognoses for treatment of middle and lower rectal cancer remain unclear because anatomical and complex surgical procedures specifically influence long-term outcomes. This study analyzes the long-term outcomes of laparoscopic versus open resection for middle and lower rectal cancer.
Patients (laparoscopic, n = 113; open, n = 123) who underwent curative resection for middle and lower rectal cancer from 2000 to 2005 participated in the study. All operations were performed by the same surgical team with extensive experience in laparoscopic and open procedures. The mean follow-up time of all patients was 74.8 months.
No statistical differences in local recurrence rate (9.1% vs. 6.4%; log-rank = 0.432; p = 0.511) and in distant recurrence rate (19.7% vs. 15.5%; log-rank = 0.505; p = 0.477) between laparoscopic and open groups were observed within 5 years. The 5-year overall survival rates of the laparoscopic and open groups were 77.9 and 78.9%, respectively; no significant statistical difference was observed between them (log-rank = 0.012; p = 0.913). The 5-year survival rates between groups were not different between stages: stage I (91.7% vs. 92.0%; p = 0.950), stage II (82.8% vs. 79.4%; p = 0.643), and stage III (66.7% vs. 70.3%; p = 0.850). However, significant statistical differences between different stages were observed (log-rank = 11.156; p = 0.004).
Laparoscopic and open surgery for middle and lower rectal cancer offer similar long-term outcomes. The continued use of laparoscopic surgery in these patients can be supported.
中低位直肠癌的治疗预后仍不明确,因为解剖和复杂的手术操作会特别影响长期疗效。本研究分析了腹腔镜与开腹手术治疗中低位直肠癌的长期疗效。
2000 年至 2005 年间,接受根治性切除术治疗中低位直肠癌的患者(腹腔镜组 113 例,开腹组 123 例)参与了本研究。所有手术均由同一外科团队完成,团队具有丰富的腹腔镜和开腹手术经验。所有患者的平均随访时间为 74.8 个月。
在 5 年内,腹腔镜组和开腹组的局部复发率(9.1% vs. 6.4%;log-rank = 0.432;p = 0.511)和远处复发率(19.7% vs. 15.5%;log-rank = 0.505;p = 0.477)差异无统计学意义。腹腔镜组和开腹组的 5 年总生存率分别为 77.9%和 78.9%,差异无统计学意义(log-rank = 0.012;p = 0.913)。两组各期生存率差异无统计学意义:Ⅰ期(91.7% vs. 92.0%;p = 0.950)、Ⅱ期(82.8% vs. 79.4%;p = 0.643)和Ⅲ期(66.7% vs. 70.3%;p = 0.850)。但是,不同分期之间的差异有统计学意义(log-rank = 11.156;p = 0.004)。
腹腔镜与开腹手术治疗中低位直肠癌的长期疗效相似。可以继续支持在这些患者中使用腹腔镜手术。